Old Web
English
Sign In
Acemap
>
authorDetail
>
Stephen E. Wang
Stephen E. Wang
Kaiser Permanente
Medicine
Randomized controlled trial
Cetuximab
Blockade
Vemurafenib
2
Papers
152
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Early case ascertainment and prospective multidisciplinary review for management of new melanoma diagnoses within an integrated healthcare system: The Kaiser Permanente Northern California experience.
2019
Journal of Clinical Oncology
Thach-Giao Truong
Kirun Chohan
Angeles Price
Helene B. Fevrier
Peter D. Peng
Maihgan Kavanagh
Maris S Jones
Alpana X Soni
Mark A Price
Barry M. Rasgon
Basil Adad
Paul A Martin
Javier Rangel
Juraj Kavecansky
Mala N. Reddy
Stephen E. Wang
Lisa J. Herrinton
Tatjana Kolevska
James P Morris
Ching-Kuo Chang
Show All
Source
Cite
Save
Citations (0)
Randomized trial of irinotecan and cetuximab with or without vemurafenib in BRAF-mutant metastatic colorectal cancer (SWOG S1406).
2017
Journal of Clinical Oncology
Scott Kopetz
Shannon McDonough
Van Karlyle Morris
Heinz Josef Lenz
Anthony M. Magliocco
Chloe E. Atreya
Luis A. Diaz
Carmen J. Allegra
Stephen E. Wang
Christopher H. Lieu
S. Gail Eckhardt
Thomas J. Semrad
Kimberly Kaberle
Katherine A. Guthrie
Howard S. Hochster
Show All
Source
Cite
Save
Citations (152)
1